Company Imunofarm Srl with Fiscal Code 1122995
recorded a turnover of 2024 of
22.516,
with a net profit of
1.825
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Imunofarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
17.976
17.997
-
-
-
17.986
17.896
17.983
17.994
22.516
Total Income - EUR
18.047
18.461
-
-
-
17.986
17.896
17.983
17.994
22.516
Total Expenses - EUR
61.891
30.405
-
-
-
24.879
24.670
22.200
18.502
20.180
Gross Profit/Loss - EUR
-43.843
-11.944
-
-
-
-6.893
-6.774
-4.217
-508
2.337
Net Profit/Loss - EUR
-43.960
-12.313
-
-
-
-7.433
-7.311
-4.756
-1.748
1.825
Employees
1
1
-
-
-
0
0
0
0
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 25.8%, from 17.994 euro in the year 2023, to 22.516 euro in 2024.
The Net Profit increased by 1.825 euro, from 0 euro in 2023, to 1.825 in the last year.
Check the financial reports for the company - Imunofarm Srl
Financial Rating - IMUNOFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Imunofarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Imunofarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Imunofarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.773 euro in 2024 which includes Inventories of
485 euro, Receivables of
1.238 euro and cash availability of
49 euro.
The company's Equity was valued at
-19.593 euro, while total Liabilities amounted to
81.360 euro.
Equity increased by 1.825 euro, from -21.538 euro in 2023, to -19.593 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Imunofarm Srl